Has the Time Arrived for Biomarker-Directed Therapy in Castration-Resistant Prostate Cancer?

JAMA Oncol. 2015 Aug;1(5):577-9. doi: 10.1001/jamaoncol.2015.1457.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / genetics*
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / genetics*
  • Humans
  • Male
  • Neoplastic Cells, Circulating / metabolism*
  • Prostatic Neoplasms, Castration-Resistant / drug therapy*
  • Prostatic Neoplasms, Castration-Resistant / genetics*
  • Receptors, Androgen / genetics*
  • Taxoids / therapeutic use*

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Receptors, Androgen
  • Taxoids